Tissue engineered technologies: regulatory pharmaceuticalization in the European Union

Alex Faulkner

Open source

DOI
10.1080/13511610.2012.723333
Published
2012-12
Container
Innovation: The European Journal of Social Science Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13511610.2012.723333,
  title = {Tissue engineered technologies: regulatory pharmaceuticalization in the European Union},
  author = {Alex Faulkner},
  year = {2012},
  journal = {Innovation: The European Journal of Social Science Research},
  doi = {10.1080/13511610.2012.723333},
  url = {https://doi.org/10.1080/13511610.2012.723333}
}

RIS

TY  - JOUR
TI  - Tissue engineered technologies: regulatory pharmaceuticalization in the European Union
AU  - Alex Faulkner
PY  - 2012
JO  - Innovation: The European Journal of Social Science Research
DO  - 10.1080/13511610.2012.723333
UR  - https://doi.org/10.1080/13511610.2012.723333
ER  - 

APA

Faulkner, A. (2012). Tissue engineered technologies: regulatory pharmaceuticalization in the European Union. Innovation: The European Journal of Social Science Research. https://doi.org/10.1080/13511610.2012.723333

Source records